Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CNS Pharmaceuticals Inc. CNSP

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
CNS Pharmaceuticals Inc. > Nasal will not allow stock price to remain below a dollar
View modes: 

Nasal will not allow stock price to remain below a dollar

Trippleline1 (12) | January 21, 2022 10:45 am

Either the company is going to have to come up with some impressive results or we're going to see a stock consolidation. It's inevitable. Too many games being played here.

RE:Nasal will not allow stock price to remain below a dollar

Trippleline1 (12) | January 21, 2022 10:47 am

Nasdaq will not allow stock price to remain below a dollar *